Effect of Diffuse-Chorioamniotic-Hemosiderosis on the development of chronic lung disease in premature infants

Effect of Diffuse-Chorioamniotic-Hemosiderosis on the development of chronic lung disease in premature infants - Diffuse-Chorioamniotic-Hemosiderosis and chronic lung disease in premature infants

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006263

Enrollment

100

Registered

2011-09-05

Start date

2011-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diffuse chorioamniotic hemosiderosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: birth weight under 1,500g

Exclusion criteria

Exclusion criteria: chromosome aberration metabolic disorder multiple anomaly

Design outcomes

Primary

Measure	Time frame
severity of chronic lung disease in premature infants	—

Countries

Japan

Contacts

Public ContactTatsuya Watanabe

Tohoku university hospital neonatal center for perinatal medicune

tatsu-w@med.tohoku.ac.jp022-717-7287

Outcome results